Health Care & Life Sciences » Biotechnology | Cerenis Therapeutics Holding

Cerenis Therapeutics Holding S.A. | Mutual Funds

Mutual Funds that own Cerenis Therapeutics Holding S.A.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Gestys Santé Biotech
60,000
0.32%
-20,000
3.74%
03/23/2018
Montaigne Capital Convictions France
40,000
0.21%
0
0.52%
08/31/2018
MAM Entreprises Familiales
25,000
0.13%
5,000
0.06%
09/30/2016
15,000
0.08%
0
0.03%
12/30/2016
MAM France PME
12,500
0.07%
4,500
0.22%
09/30/2016
CCR Actions Biotech
3,715
0.02%
3,715
0.05%
12/30/2016
Martin Maurel Vie
1,640
0.01%
1,640
0%
12/31/2015
AVIP Vie
820
0%
820
0%
12/31/2015
Gallica
0
0%
-36,000
0%
06/30/2017
Amilton Small Caps
0
0%
-50,000
0%
06/30/2017

About Cerenis Therapeutics Holding

View Profile
Address
33-43, av. Georges Pompidou- Bât. D2
Balma Midi-Pyrenees 31130
France
Employees -
Website http://www.cerenis.com
Updated 07/08/2019
Cerenis Therapeutics Holding SA is a biopharmaceutical company, which engages in development of high density lipoprotein therapies for the treatment of cardiovascular and metabolic diseases. Its therapies consist of CER 001 and 209. The company was founded by Jean-Louis Dasseux on March 24, 2005 and is headquartered in Labege, France.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.